Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 908-917-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 09 Aug 2016 - 20 Jan 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted in 1997
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Medicines & Healthcare products Regulatory Agency, United Kingdom
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Reaction mass of hydroxyethyl laurate and ethylenedilaurate
- EC Number:
- 908-917-6
- Molecular formula:
- C14H28O3 C26H50O4
- IUPAC Name:
- Reaction mass of hydroxyethyl laurate and ethylenedilaurate
Constituent 1
- Specific details on test material used for the study:
- The test item dilutions were prepared in acetone on the day of each experiment. No correction for purity was required. Acetone is toxic to the bacterial cells at 0.1 mL (100 μL) after employing the pre-incubation modification; therefore all of the formulations for Experiment 2 were prepared at concentrations two times greater than required on Vogel-Bonner agar plates. To compensate, each formulation was dosed using 0.05 mL (50 μL) aliquots (Maron et al., 1981). Prior to use, the solvent was dried to remove water using molecular sieves i.e. 2 mm sodium alumino-silicate pellets with a nominal pore diameter of 4 x 10-4 microns.
All formulations were used within four hours of preparation and were assumed to be stable for this period. Analysis for concentration, homogeneity and stability of the test item formulations is not a requirement of the test guidelines and was, therefore, not determined.
Method
- Target gene:
- his operon
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: University of California, Berkeley, on culture discs, on 04 August 1995, British Industrial Biological Research Association, on a nutrient agar plate, on 17 August 1987
MEDIA USED
- Type and identity of media: Top agar was prepared using 0.6% Bacto agar (lot number 5223985 06/20) and 0.5% sodium chloride with 5 mL of 1.0 mM histidine and 1.0 mM biotin or 1.0 mM tryptophan solution added to each 100 mL of top agar. Vogel-Bonner Minimal agar plates were purchased from SGL Ltd (lot numbers 43372 02/17 and 43406 02/17).
- Properly maintained: yes
- Periodically 'cleansed' against high spontaneous background: yes - Additional strain / cell type characteristics:
- DNA polymerase A deficient
- Metabolic activation:
- with and without
- Metabolic activation system:
- microsomal preparations (S9 mix), prepared from rat livers treated with a mixture known to induce an elevated level of these enzymes.
- Test concentrations with justification for top dose:
- 1st Experiment: 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate with and without metabolic activation
2nd Experiment:
Salmonella strain TA100 (absence of S9): 0.05, 0.15, 0.5, 1.5, 5, 15, 50, 150 μg/plate.
Salmonella strains TA1535, TA98 and TA1537 (absence of S9): 0.15, 0.5, 1.5, 5, 15, 50, 150, 500 μg/plate.
Salmonella strains TA1535 and TA100 (presence of S9): 0.5, 1.5, 5, 15, 50, 150, 500, 1500 μg/plate.
E.coli strain WP2uvrA (absence and presence of S9) and Salmonella strains TA98 and TA1537 (presence of S9): 1.5, 5, 15, 50, 150, 500, 1500, 5000 μg/plate.
The top dose was selected based on cytotoxicity in each strain with or without metabolic activation. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
- Justification for choice of solvent/vehicle: The test item was insoluble in sterile distilled water, dimethyl sulphoxide and dimethyl formamide at 50 mg/mL but was fully soluble in acetone at 100 mg/mL in solubility checks performed in-house
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- positive controls in the absence of S9-mix
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- other: 2-Aminoanthracene (2AA)
- Remarks:
- positive controls in the presence of S9-mix
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation) and preincubation (in buffer without metabolic activation or instead in S9-mix for metabolic activation)
All of the plates were incubated at 37 ± 3°C for approximately 48 h and scored for the presence of revertant colonies using an automated colony counting system. The plates were viewed microscopically for evidence of thinning (toxicity). Manual counts were required at 5000 µg/plate because of test item precipitation.
DURATION
- Exposure duration: 48 h after 20 min preincubation
NUMBER OF REPLICATIONS: 3 (triplicates)
As the result of Experiment 1 was deemed negative, Experiment 2 was performed using the pre-incubation method with and without metabolic activation.
Without metabolic activation:
0.1 mL of the appropriate bacterial strain culture, 0.5 mL of phosphate buffer and 0.05 mL of the test item formulation or solvent vehicle or 0.1 mL of appropriate positive control were incubated at 37 ± 3 °C for 20 min (with shaking) prior to addition of 2 mL of molten, trace amino-acid supplemented media and subsequent plating onto Vogel-Bonner plates. Negative (untreated) controls were also performed on the same day as the mutation test employing the plate incorporation method.
With metabolic activation:
The procedure was the same as without metabolic activation, except that following the addition of the test item formulation and bacterial strain culture, 0.5 mL of S9-mix was added to the tube instead of phosphate buffer, prior to incubation at 37 ± 3 °C for 20 minutes (with shaking) and addition of molten, trace amino-acid supplemented media. - Evaluation criteria:
- A test item was considered non-mutagenic (negative) in the test system if the following criteria were not met:
1. A dose-related increase in mutant frequency over the dose range tested.
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. Statistical analysis of data as determined by UKEMS (Mahon et al., 1989).
5. Fold increase greater than two times the concurrent solvent control for any tester strain (especially if accompanied by an out-of-historical range response (Cariello and Piegorsch, 1996)). - Statistics:
- Statistical significance was confirmed by using Dunnetts Regression Analysis (* = p < 0.05) for those values that indicate statistically significant increases in the frequency of revertant colonies compared to the concurrent solvent control.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: A test item precipitate (white and particulate in appearance) was noted under a low power microscope at 1500 μg/plate and by eye at 5000 µg/plate, this observation did not prevent the scoring of revertant colonies.
RANGE-FINDING/SCREENING STUDIES:
The results of the range finding study were included as experiment 1.
CYTOTOXICITY
First experiment: maximum dose of 5000 µg/plate. The test item caused a visible reduction in the growth of the bacterial background lawns of all of the Salmonella tester strains initially from 150 μg/plate in the absence of S9-mix and 1500 μg/plate in the presence S9-mix. No toxicity was noted to Escherichia coli strain WP2uvrA in either the absence or presence S9-mix. Consequently, the toxic limit or the maximum recommended dose concentration of the test item was employed as the maximum dose in the second mutation test, depending on bacterial strain type and presence or absence of S9-mix. The test item induced a much stronger toxic response in the second mutation test (employing the pre-incubation method), with weakened bacterial background lawns noted in the absence of S9-mix from 15 μg/plate (TA100), 50 μg/plate (TA1535, TA98 and TA1537) and 150 μg/plate (WP2uvrA). In the presence S9-mix, weakened bacterial background lawns were noted to the Salmonella strains only from 500 μg/plate (TA100, TA1535 and TA98) and 1500 μg/plate (TA1537). No toxicity was noted to Escherichia coli strain WP2uvrA dosed in the presence S9-mix in the second mutation test. The sensitivity of the bacterial tester strains to the toxicity of the test item varied slightly between strain type, exposures with or without S9-mix and experimental methodology.
HISTORICAL CONTROL DATA
- Positive historical control data: provided for 2015 and 2016
- Negative (solvent/vehicle) historical control data: provided for 2015 and 2016
see attached document
Any other information on results incl. tables
There were no significant increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 1 (plate incorporation method). Similarly, no toxicologically significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 2 (pre-incubation method). A small, statistically significant increase in TA98 revertant colony frequency was observed in the presence of S9-mix at 50 μg/plate in the second mutation test. This increase was considered to be of no biological relevance because there was no evidence of a dose-response relationship or reproducibility. Furthermore, the individual revertant colony counts at 50 μg/plate were within the in-house historical untreated/vehicle control range for the tester strain and the fold increase was only 1.6 times the concurrent vehicle control.
The vehicle (acetone) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with or without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
Table 1: Mean number of revertants in experiment 1
Experiment I |
without S9 |
|
|
|
|
|
TA100 |
TA1535 |
WP2 uvrA |
TA98 |
TA1537 |
Vehicle (acetone) |
87 |
12 |
23 |
13 |
10 |
1.5 µg |
89 |
14 |
13 |
15 |
12 |
5 µg |
76 |
12 |
13 |
18 |
12 |
15 µg |
101 |
14 |
17 |
18 |
13 |
50 µg |
93 |
12 |
19 |
17 |
11 |
150 µg |
94 S |
16 |
17 |
15 |
7 |
500 µg |
78 S |
8 S |
18 |
14 S |
7 S |
1500 µg |
23 S |
8 S |
12 |
13 S |
0 V |
5000 µg |
0 VP |
0 VP |
11 P |
8 SP |
0 VP |
N-ethyl-N'-nitro-N-nitrosoguanidine |
524 |
128 |
553 |
|
|
4-Nitroquinoline-1-oxide |
|
|
|
173 |
|
9-Aminoacridine |
|
|
|
|
610 |
Experiment I |
with S9 |
|
|
|
|
|
TA100 |
TA1535 |
WP2 uvrA |
TA98 |
TA1537 |
Vehicle (acetone) |
94 |
13 |
21 |
22 |
19 |
1.5 µg |
97 |
11 |
20 |
21 |
15 |
5 µg |
88 |
13 |
21 |
20 |
15 |
15 µg |
94 |
11 |
19 |
25 |
12 |
50 µg |
97 |
17 |
18 |
22 |
15 |
150 µg |
98 |
14 |
19 |
20 |
12 |
500 µg |
77 |
11 |
23 |
22 |
11 |
1500 µg |
74 S |
7 S |
19 |
18 |
8 |
5000 µg |
32 SP |
7 SP |
22 P |
12 SP |
3 SP |
2-aminoanthracene |
747 |
214 |
224 |
|
448 |
Benzo(a)pyrene |
|
|
|
111 |
|
P = precipitation; S = sparse bacterial background law, V = very weak bacterial background lawn
Table 2: Mean number of revertants in experiment II
Experiment II |
without S9 |
|
|
|
|
|
TA100 |
TA1535 |
WP2 uvrA |
TA98 |
TA1537 |
Vehicle (acetone) |
82 |
18 |
20 |
15 |
8 |
0.05 µg |
82 |
NT |
NT |
NT |
NT |
0.15 µg |
80 |
8 |
NT |
17 |
9 |
0.5 µg |
75 |
11 |
NT |
21 |
7 |
1.5 µg |
82 |
13 |
17 |
19 |
8 |
5 µg |
85 |
13 |
20 |
14 |
6 |
15 µg |
81 S |
12 |
20 |
14 |
5 |
50 µg |
0 T |
0 T |
17 |
18 S |
0 T |
150 µg |
0 T |
0 T |
14 |
0 T |
0 T |
500 µg |
NT |
0 T |
18 S |
0 T |
0 T |
1500 µg |
NT |
NT |
0 V |
NT |
NT |
5000 µg |
NT |
NT |
0 VP |
NT |
NT |
N-ethyl-N'-nitro-N-nitrosoguanidine |
721 |
3264 |
96 |
|
|
4-Nitroquinoline-1-oxide |
|
|
|
151 |
|
9-Aminoacridine |
|
|
|
|
465 |
Experiment II |
with S9 |
|
|
|
|
|
TA100 |
TA1535 |
WP2 uvrA |
TA98 |
TA1537 |
Vehicle (acetone) |
89 |
13 |
25 |
16 |
8 |
0.5 µg |
76 |
14 |
NT |
NT |
NT |
1.5 µg |
89 |
12 |
22 |
20 |
11 |
5 µg |
77 |
10 |
25 |
23 |
9 |
15 µg |
78 |
12 |
23 |
21 |
10 |
50 µg |
86 |
12 |
27 |
26** |
11 |
150 µg |
81 |
10 |
26 |
18 |
8 |
500 µg |
0 V |
0 V |
26 |
14 S |
11 |
1500 µg |
0 V |
0 V |
24 |
0 V |
0 V |
5000 µg |
NT |
NT |
22 P |
0 VP |
0 TP |
2-aminoanthracene |
1314 |
197 |
260 |
|
210 |
Benzo(a)pyrene |
|
|
|
64 |
|
P = precipitation; S = sparse bacterial background law, V = very weak bacterial background lawn, T = toxic, no bacterial background lawn, NT = not tested
** p<0.01
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.